AUG 08, 2019 12:17 PM PDT

Gel Reduces Surgical Scarring

WRITTEN BY: Nouran Amin

Scientists have found that spraying a gel on the internal tissues of animal post-surgery has significantly reduced scarring—which can often lead to devastating consequences. The gel—known as PNP 1:10—is a polymer-nanoparticle hydrogel and was originally developed for drug delivery but was instead found to be an effect medication for adhesion prevention than most currently marketed.

"The difference between what we saw after using the gel and what we normally see after surgery was drastic," said Joseph Woo, MD, professor and chair of cardiothoracic surgery and the Norman E. Shumway Professor.

Historical materials used to prevent adhesion ranged from animal membranes to sheets of rubber and mineral oil. Presently, adhesion barriers approved by the Food and Drug Administration are ineffective and difficult to implement and thus are rarely used in post-surgical interventions. Regardless, adhesions form 95% of the time after surgery and although some may be harmless, others can lead to intestinal compression and life-threatening blockages according to the surgical location.

The PNP 1:10 gel study on animals was published in Nature Biomedical Engineering and describes how the gel was used after cardiac surgery on mice and was found to have the ideal tension. "It covers all of the irregular surfaces of the heart, adhering to the tissues, but not to itself," Woo said.

“The gel doesn't prevent tissues from moving around," said Eric Appel, PhD, an assistant professor of materials science and engineering. "It simply provides a physical barrier to keep them from sticking to each other."

Learn more about surgical wound healing:

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 18, 2019
Clinical & Molecular DX
NOV 18, 2019
Muscular Dystrophy Drug by Sarepta Therapeutics: Approval or Rejection by Drug Regulating Authorities?
Duchenne Muscular Dystrophy (DMD is a rare, genetic disorder that hampers muscle movement and is the most common pediatric muscular dystrophy. I...
NOV 18, 2019
Genetics & Genomics
NOV 18, 2019
Breast Cancer Drug Increases Survival for Prostate Cancer Patients
A breast cancer drug is better at treating advanced prostate cancer in some men than current therapies, a clinical trial shows....
NOV 18, 2019
Cardiology
NOV 18, 2019
Heart Attacks Without The Risk
Following a heart attack, as the heart heals, scar tissue forms. This issue is less flexible than healthy heart tissue and may encumber the heart's abi...
NOV 18, 2019
Cannabis Sciences
NOV 18, 2019
CBD Extract for Cannabis Addiction
Some people believe the secret to curing a hangover is to drink more alcohol the morning after a night of binge drinking - “the hair of the dog that...
NOV 18, 2019
Neuroscience
NOV 18, 2019
First Drug to Slow Progression of Alzheimer's Shows Promise
An estimated 5.8 million people living in the US have Alzheimer’s disease. Currently, no cure is available and any drugs have only been able to treat...
NOV 18, 2019
Genetics & Genomics
NOV 18, 2019
Can CRISPR Replace Antibiotics?
Antibiotic-resistant infections claim around 700,000 lives per year, with estimates saying that this number could swell to 10 million by 2050 (Jacobs: 2019...
Loading Comments...